123 results on '"Galván, A."'
Search Results
2. Effectiveness of dutasteride in a large series of patients with frontal fibrosing alopecia in real clinical practice
3. HIV and mpox: Evaluation of clinical course and outcomes from an international dermatologic registry
4. Prospective evaluation of blood pressure, heart rate, and side effects in hypertensive patients using low-dose oral minoxidil for hair loss
5. Low-dose oral minoxidil for treatment of androgenetic alopecia and telogen effluvium in a pediatric population: A descriptive study
6. Topical dapsone for folliculitis decalvans: A retrospective cohort study
7. Frontal fibrosing alopecia and cutaneous comorbidities: A potential relationship with rosacea
8. Development and validation of the Frontal Fibrosing Alopecia Severity Score
9. Acknowledging the pseudo “fringe sign” in frontal fibrosing alopecia has diagnostic and prognostic implications
10. Updated diagnostic criteria for frontal fibrosing alopecia
11. Beard loss in men with frontal fibrosing alopecia
12. Low-dose oral minoxidil for treatment of androgenetic alopecia and telogen effluvium in a pediatric population: A descriptive study
13. Folliculitis decalvans microbiologic signature is specific for disease clinical phenotype
14. Time of onset and duration of post-COVID-19 acute telogen effluvium
15. Pulse corticosteroid therapy with oral dexamethasone for the treatment of adult alopecia totalis and universalis
16. Treatment of recalcitrant adult alopecia areata universalis with oral azathioprine
17. Antiandrogenic drugs, a therapeutic option for frontal fibrosing alopecia patients
18. Reply: Treatment of folliculitis decalvans with photodynamic therapy
19. Oral minoxidil improves background hair thickness in lichen planopilaris
20. Response to “Reply to effectiveness of dutasteride in a large series of patients with FFA in real clinical practice”
21. Trichoscopic findings of discoid lupus erythematosus alopecia: A cross-sectional study
22. Depression of the frontal veins: A new clinical sign of frontal fibrosing alopecia
23. Trichoscopic features of frontal fibrosing alopecia: Results in 249 patients
24. 44220 Genotyping of the rs1800440 polymorphism in CYP1B1 gene and the rs9258883 polymorphism in HLA-B gene in a Spanish cohort of 223 patients with frontal fibrosing alopecia
25. 42577 Application of the new clinical guidelines in frontal fibrosing alopecia of the male
26. 41915 Improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata achieving scalp hair regrowth: results from two randomized controlled trials
27. 44096 Efficacy in Subgroups related to Disease Characteristics in Patients with Alopecia Areata from BRAVE-AA1 and BRAVE-AA2
28. 44179 Characterization of subclinical atherosclerosis in chronic severe alopecia areata.
29. 43129 A series of 69 COVID-related dermatosis with biopsy, immunohistochemistry with antiSpike 3 and in situ hybridization and PCR: a critical reappraisal of COVID-19 skin involvement.
30. Reply to ‘Frontal fibrosing alopecia’
31. Frontal fibrosing alopecia: A multicenter review of 355 patients
32. Epidemiologic and clinical features of pattern III frontal fibrosing alopecia (pseudo fringe type): A multicenter series of 38 patients
33. Reply to comment on: The Gabrin sign
34. Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients – the 'Gabrin sign'
35. 15640 Effectiveness and safety of oral dutasteride for male androgenetic alopecia in real clinical practice: A descriptive unicenter study
36. Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
37. Asymptomatic crusted lesions
38. Folliculocystic and collagen hamartoma of tuberous sclerosis complex
39. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
40. Hair transplant in frontal fibrosing alopecia: A multicenter review of 51 patients
41. Reply to: “Comment on ‘Folliculitis decalvans: Effectiveness of therapies and prognostic factors in a multicenter series of 60 patients with long-term follow-up’”
42. Reply to: “Response to ‘Development and validation of the Frontal Fibrosing Alopecia Severity Score’”
43. Folliculitis decalvans: Effectiveness of therapies and prognostic factors in a multicenter series of 60 patients with long-term follow-up
44. Steroid-induced changes noted on trichoscopy of patients with frontal fibrosing alopecia
45. Comment on “Low dose oral minoxidil for treating alopecia: A 3-year North American retrospective case series”: Adding further evidence about side effects
46. Characterization and management of hypertrichosis induced by low-dose oral minoxidil in the treatment of hair loss
47. 17562 Genetic anticipation in frontal fibrosing alopecia: An inadequate follow-up time bias
48. 17043 Frontal fibrosing alopecia severity score: A 3-year prospective study
49. Reply to: “Regarding trichoscopy of dissecting cellulitis of the scalp”
50. Trichoscopy of dissecting cellulitis of the scalp: Exclamation mark hairs and white dots as markers of disease chronicity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.